http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002510304-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 |
| filingDate | 1998-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002510304-A |
| titleOfInvention | Use of a vitamin D compound to prevent transplant rejection |
| abstract | (57) [Summary]nDisclosed is a method of alleviating transplant rejection in a transplant recipient, comprising administering a predetermined dose of a vitamin D compound effective to prevent transplant rejection. Preferably, the susceptibility of the recipient to an opportunistic infection is not compromised. Also preferably, no bone demineralization occurs in the recipient. |
| priorityDate | 1997-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.